Some additional insights from our latest NGS DxBook report, this time focusing on the competitive landscape of sample prep vendors in the clinical oncology. Here are some highlights:

• Labs offering 2+ panels leverage a variety of sample prep vendors to meet their specific needs, demonstrating the ability of sample prep vendors to continue to differentiate to meet specific downstream needs

• Smaller sample prep vendors shine in specialized segments, providing unique and differentiated products across various panel types, including solid tumors and liquid biopsies.

• The sample prep market is ripe for growth! Vendors that deliver accurate, robust, and cost-effective assays can significantly penetrate the market. Early engagement and involvement in lab workflows are critical to success.

• Large-scale providers and academic medical centers often use custom solutions ("homebrew") for flexibility, while most decentralized labs opt for off-the-shelf kits with minimal customization.

‍

‍